Our latest publication is a position paper from the ESOT Advanced Therapy Medicinal Products (ATMP) task force. Named “ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care“, the document discusses ways to address hurdles and effectively improve access and care in this field of medicine. ATMP therapies
Category: Cell
Maximise Your Impact with ESOT!
Improving transplant patient outcomes is at the forefront of our mission and, we are eager to collaborate with research teams who share the common goal of improving the lives of those hindered by inequitable access to life-changing treatments and procedures. Here’s why our involvement can be a game-changer for your project: Unmatched Expertise: With a
ESOT Masterclass Now Accepting Applications!
Aimed at young professional working in solid organ transplant, this Masterclass will provide crucial insight into the cutting-edge technologies that are about to revolutionise the transplantation field, including cell-free DNA, new plasma, urinary and immune function biomarkers, gene-expression profiling, as well as recent advances on HLA and non-HLA antibodies.
ESOT manual for clinical practice guidelines
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
ECTORS Call for nominations – DEADLINE EXTENDED
ECTORS, the European Cell Therapy and Organ Regeneration Section of ESOT, would like to announce a call for nominations for two new Board members. The new ECTORS Board Members will hold office for four years (2023-2027), starting at the ESOT Congress, September 2023. All ESOT/ECTORS affiliates active in the field of regenerative medicine or cell
Hope vs hype
“What has been achieved in tissue engineering and regenerative medicine?” Tissue engineering and organ regeneration expert, Ekaterine Berishvili, discusses the progress, opportunities and challenges of regeneration and repair in organ transplantation.
ECTORS call for nominations
ECTORS, the European Cell Therapy and Organ Regeneration Section of ESOT, would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their applications for the positions. The Board reserves the right to shortlist candidates on the
ITS Meeting 2022 – Abstract submission deadline EXTENDED
Extended deadline for the #ITSmeeting abstract submission: 19 January 2022 [at 23:59 CET]
WEBINAR: What you need to know about vaccinating your kidney transplanted patients against COVID-19
This educational webinar will discuss the efficacy of current COVID-19 vaccine strategies for transplanted patients. The first talk will focus on the experience with heterologous vaccinations and the pro´s and con´s for vector vaccines in transplant patients. The second talk summarises previous studies on second and third booster (homogenous and heterologous) vaccinations – and gives
ECTORS Call for nominations
We would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their application for the positions. The Board reserves the right to shortlist candidates on the basis of their specialty. If you wish to apply, please
